Benjamin Morgan is a counsel in the firm’s Technology and Life Sciences group and Capital Markets practice. His practice covers advising prospective issuers, financial institutions and private equity investors on equity capital market transactions (including IPOs, secondary offerings and selldowns) as well as assisting on general public company advisory matters (including in relation to an issuer’s continuing obligations following its listing). Mr. Morgan also has extensive experience advising underwriters on numerous equity raises and spent time on secondment at Goldman Sachs’ IBD legal team in London.





Mr. Morgan’s experience includes advising:

  • Pfizer on the demerger and standalone listing of Haleon*
  • PensionBee on its transfer from the London Stock Exchange’s high growth segment to the exchange’s premium segment and admission to the Financial Conduct Authority’s (FCA) Official List*
  • Swiss Re on its £540 million selldown in Pheonix Group Holdings by way of an ABB*
  • Stelrad Radiators on its £95 million IPO and premium listing*
  • BofA Merrill Lynch and BNP Paribas as underwriters on Baltic Classifieds Group’s £330 million IPO and premium listing*
  • PensionBee on its £60 million IPO (including its customer offer) on the London Stock Exchange’s high growth segment*
  • THG on its £1.9 billion IPO and standard listing*
  • easyJet on its £700 million cashbox placing*
  • Underwriting syndicate comprising Citi, Credit Suisse, HSBC, KKR Capital Markets, Barclays and Goldman Sachs on Calisen’s £305 million IPO and premium listing*
  • RBC, Jefferies and Keefe, Bruyette & Woods (a Stifel company) on Metro Bank’s £375 million documented placing*
  • Stifel and Jefferies as underwriters on DWF Group’s £96 million IPO and premium listing*
  • Nova Ljubljanska Banka on its €608 million IPO and standard listing of global depositary receipts*
  • RBC, Jefferies and Keefe, Bruyette & Woods (a Stifel company) on Metro Bank's £303 million undocumented placing*
  • J.P. Morgan, RBC and Macqaurie as underwriters on Amigo Loans’ £327 million IPO and premium listing*
  • Baupost on its selldown in Bakkavor’s £244 million IPO and premium listing*
  • PureGym on its postponed IPO and premium listing*
  • Numis and Barclays as underwriters on The Gym Group’s £123 million IPO and premium listing*
  • BofA Merrill Lynch, Deutsche Bank, J.P. Morgan, Morgan Stanley and Numis as underwriters on Auto Trader’s £1.4 billion IPO and premium listing*
  • Barclays, HSBC and RBC as underwriters on John Laing’s £249 million IPO and premium listing*
  • B&M Retail on its £1 billion IPO and premium listing*
  • Barclays on its £5.9 billion rights issue*

* denotes experience prior to joining Goodwin.






L.P.C., 2008
College of Law London
GDL, 2007
College of Law (now known as University of Law)
B.A., (Hons) Modern Languages, 2006
Durham University



England & Wales
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique